Efficacy of Real-time Feedback Exercise Therapy in Patients Following Total Hip Arthroplasty

August 4, 2025 updated by: Klaus Widhalm

Efficacy of Real-time Feedback Exercise Therapy in Patients Following Total Hip Arthroplasty: a Pilot Cluster-randomized Controlled Trial

This pilot cluster-randomized, two-arm parallel-group controlled trial, aims at enhancing the understanding of the effects of real-time feedback on functional deficits as knee valgus thrust, pelvic drop, and lateral trunk lean after total hip arthroplasty. Biomechanical and patient-reported outcomes will be assessed after a total hip arthroplasty as well as at three and six months follow-ups. The primary research question is, whether digital real-time feedback supported home-exercising improves the control of the frontal knee range of motion, pelvic obliquity, and lateral trunk lean, superior to exercising supported by written instructions as comparator. The secondary aspect focuses on potential differences between groups concerning aspects of quality of life, function, and physical activity. Tertiary functional outcomes between groups will be compared for reasons of quantification movement quality.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

38

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Vienna, Austria, 1130
        • Orthopaedic Hospital Vienna Speising

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • age from 50-75 years
  • body mass index from 18.5 to 29.99 kg/m²
  • able to walk without walking aids at baseline assessment
  • scheduled for elective unilateral total hip arthroplasty surgery
  • willing to comply with all study related procedures and provide informed consent

Exclusion Criteria:

  • symptoms of delayed healing concerning the implant
  • cardio-respiratory symptoms limiting exercise therapy (for example severe heart disease)
  • symptoms of musculoskeletal or cardio-respiratory overload
  • neuro-motor diseases (for example previous Stroke, Multiple Sclerosis, Morbus Parkinson Disease)
  • other reasons which would lead to obvious limitations concerning their participation in the intervention (for example severe contralateral osteoarthritis (OA), lower extremity fractures within previous 12 months, other elective lower extremity surgery within 6 months, inadequacy in German concerning questionnaires and exercise instructions, mentally unable to participate)
  • non-adherence (see definition under "therapeutic adherence").

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group (IG)
IG will perform the home-exercise program supported by the digital real-time exercise feedback prototype for digitally guided training.
Participants will participate in a 90 minutes supervised group exercise therapy program 2 times a week for 8 consecutive weeks.
Active Comparator: Control Group (CG)
The CG will perform a usual care home-exercise by means of printed hand-outs describing each exercise.
Participants will participate in a 90 minutes supervised group exercise therapy program 2 times a week for 8 consecutive weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frontal knee angle range of motion Pelvic obliquity angle range of motion Frontal trunk angle range of motion
Time Frame: Baseline 4 weeks post-surgery; 3-months post-surgery; 6-months post-surgery
Above listed angles derived from assessed Activities of Daily Living (ADL) tasks
Baseline 4 weeks post-surgery; 3-months post-surgery; 6-months post-surgery

Secondary Outcome Measures

Outcome Measure
Time Frame
Harris Hip Score (HHS) Hip Osteoarthritis Outcome Score (HOOS) Short-Form-Health Survey (SF12) International Physical Activity Questionnaire - short form (IPAQ) if applicable: Knee Injury and Osteoarthritis Outcome Score (KOOS)
Time Frame: Baseline 4 weeks post-surgery; 3-months post-surgery; 6-months post-surgery
Baseline 4 weeks post-surgery; 3-months post-surgery; 6-months post-surgery

Other Outcome Measures

Outcome Measure
Time Frame
3D-movement-analysis parameters (kinematic, kinetic, spatio-temporal)
Time Frame: Baseline 4 weeks post-surgery; 3-months post-surgery; 6-months post-surgery
Baseline 4 weeks post-surgery; 3-months post-surgery; 6-months post-surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Klaus Widhalm, FH Campus Wien, University of Applied Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 10, 2024

Primary Completion (Actual)

April 15, 2025

Study Completion (Actual)

May 5, 2025

Study Registration Dates

First Submitted

November 30, 2023

First Submitted That Met QC Criteria

November 30, 2023

First Posted (Actual)

December 7, 2023

Study Record Updates

Last Update Posted (Actual)

August 8, 2025

Last Update Submitted That Met QC Criteria

August 4, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • CIP_SETT_RCT-THA

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Time Frame

The study protocol including the statistic analysis plan will be submitted for publication in Trials Journal at begin of 2024.

The final results will be submitted for publication to a relevant journal by the end of 2025.

IPD Sharing Access Criteria

Open Access publication

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Replacement

Clinical Trials on Supervised group exercise therapy

Subscribe